Treatment of good prognosis germ cell cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN35399995

Enrollment

800

Registered

2001-02-28

Start date

1995-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testicular cancer Cancer Testicular

Interventions

There are four groups: 1. The first receives three cycles of BEP chemotherapy over a five day schedule 2. The second group receives three cycles of BEP + 1 cycle of EP chemotherapy over a 5 day schedu

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Seminoma or non-seminoma - testis or retroperitoneal primary, alpha-fetoprotein (AFP) =1000 iu/l human chorionic gonadotrophin (HCG) =5000 iu/l, lactic dehydrogenase (LDH) =1.5 x N 2. No liver, bone or brain mets seminoma - stage =2 C or relapse after radiotherapy and any primary site and LDH 3. No liver bone or brain mets

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Time to progression 2. Quality of life 3. Morbidity 4. Survival time	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026